PTGX icon

Protagonist Therapeutics

136 hedge funds and large institutions have $1.22B invested in Protagonist Therapeutics in 2023 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 44 increasing their positions, 44 reducing their positions, and 32 closing their positions.

Holders
136
Holders Change
Holders Change %
0%
% of All Funds
2.18%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.05%
New
33
Increased
44
Reduced
44
Closed
32
Calls
$42.3M
Puts
$13.2M
Net Calls
+$29.1M
Net Calls Change
+$21.3M
Name Market Value Shares Shares
Change
Shares
Change %
GCP
151
GSA Capital Partners
United Kingdom
-55,839 Closed
AQR Capital Management
152
AQR Capital Management
Connecticut
-40,970 Closed
FRM
153
Fox Run Management
Connecticut
-28,970 Closed
E
154
Ergoteles
New York
-23,000 Closed
ACM
155
Aquatic Capital Management
Illinois
-22,300 Closed
CANY
156
Caxton Associates (New York)
New York
-21,853 Closed
Squarepoint
157
Squarepoint
New York
-21,770 Closed
YIH
158
Y-Intercept (HK)
Hong Kong
-14,318 Closed
DCM
159
Dupont Capital Management
Delaware
-13,127 Closed
XT
160
XTX Topco
Cayman Islands
-12,942 Closed
AGM
161
Alpine Global Management
New York
-10,279 Closed
OQS
162
Occudo Quantitative Strategies
Florida
-10,198 Closed
Acadian Asset Management
163
Acadian Asset Management
Massachusetts
-9,199 Closed
QT
164
Quantbot Technologies
New York
-6,700 Closed
Lazard Asset Management
165
Lazard Asset Management
New York
-6,404 Closed
Group One Trading
166
Group One Trading
Illinois
-1,307 Closed
FGAM
167
Financial Gravity Asset Management
Texas
-11 Closed
CFGS
168
Concourse Financial Group Securities
Alabama
MCM
169
Moore Capital Management
New York
HT
170
HAP Trading
New York
BFM
171
Boothbay Fund Management
New York
PI
172
PEAK6 Investments
Illinois
C
173
Covestor
United Kingdom
$0 10
IC
174
Ikarian Capital
Texas